Related Experiment Video
Updated: Dec 29, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
The In Vitro Activity of Essential Oils against Helicobacter Pylori Growth and Urease Activity
Izabela Korona-Glowniak1, Anna Glowniak-Lipa1, Agnieszka Ludwiczuk2
1Department of Pharmaceutical Microbiology, Medical University in Lublin, 1 Chodzki Str., 20-093 Lublin, Poland.
Abstract:
The anti-H. pylori properties of 26 different commercial essential oils were examined in vitro by MIC (minimal inhibitory concentration) determination for the reference strain H. pylori ATCC 43504. We selected 9 essential oils with different anti-Helicobacter activities and established their phytochemical composition and urease inhibition activities. Phytochemical analysis of the selected essential oils by GC-MS method and antioxidant activity were performed. The phenol red method was used to screen the effect of essential oils on urease activity expressed as IC50 (the half of maximal inhibitory concentration). The most active essential oils, with MIC = 15.6 mg/L, were thyme, lemongrass, cedarwood and lemon balm oils; MIC = 31.3 mg/L-oregano oil; MIC = 62.5 mg/L-tea tree oil; MIC = 125 mg/L-pine needle, lemon and silver fir oils with bactericidal effect. Urease activity was inhibited by these oils with IC50 ranged from 5.3 to > 1049.9 mg/L. The most active was cedarwood oil (IC50 = 5.3 mg/L), inhibiting urease at sub-MIC concentrations (MIC = 15.6 mg/L). The statistical principal component analysis allowed for the division of the oils into three phytochemical groups differing in their anti-H. pylori activity. To summarize, the activity in vitro of the five essential oils silver fir, pine needle, tea tree, lemongrass, and cedarwood oils against H. pylori was found in this paper for the first time. The most active against clinical strains of H. pylori were cedar wood and oregano oils. Moreover, cedarwood oil inhibited the urease activity at subinhibitory concentrations. This essential oil can be regarded as a useful component of the plant preparations supporting the eradication H. pylori therapy.
Insights
Essential oils like cedarwood and oregano show potent anti-H. pylori activity. Cedarwood oil also inhibits urease, suggesting its potential in therapies for H. pylori infections.
Area of Science:
- Microbiology
- Natural Products Chemistry
- Pharmacology
Background:
- Helicobacter pylori (H. pylori) is a significant human pathogen.
- Antibiotic resistance in H. pylori necessitates alternative therapeutic strategies.
- Essential oils (EOs) represent a potential source of novel antimicrobial agents.
Purpose of the Study:
- To evaluate the in vitro anti-H. pylori activity of various commercial essential oils.
- To determine the phytochemical composition and urease inhibition activity of selected EOs.
- To identify EOs effective against both reference and clinical strains of H. pylori.
Main Methods:
- Minimal Inhibitory Concentration (MIC) determination for 26 EOs against H. pylori ATCC 43504.
- Gas Chromatography-Mass Spectrometry (GC-MS) for phytochemical analysis.
- Phenol red method to assess urease inhibition (IC50).
- Principal Component Analysis (PCA) for grouping EOs based on phytochemicals and activity.
Main Results:
- Thyme, lemongrass, cedarwood, and lemon balm oils exhibited the highest anti-H. pylori activity (MIC = 15.6 mg/L).
- Cedarwood oil demonstrated significant urease inhibition (IC50 = 5.3 mg/L), even at sub-MIC levels.
- Cedarwood and oregano oils were most effective against clinical H. pylori strains.
- PCA identified three distinct phytochemical groups correlating with anti-H. pylori efficacy.
Conclusions:
- Several essential oils, notably cedarwood and oregano, possess significant in vitro activity against H. pylori.
- Cedarwood oil's dual action (anti-H. pylori and urease inhibition) makes it a promising candidate for complementary therapy.
- This study highlights the potential of specific EOs as adjuncts in H. pylori eradication strategies.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Antimicrobial Effectiveness

